The World Health Organisation (WHO) has not commented on this development yet.
Most of the vaccines, in general, have demonstrated their effectiveness against new variants including Delta in preventing hospitalisations and deaths. However, their effectiveness seems to be waning rapidly over time (6 to 9 months after 2nd dose), necessitating booster doses to those at high risk and to all adults if sufficient vaccine supplies are available.